Priyanka Joshi

About

I am excited about developing new interdisciplinary quantitative approaches and tools to answer fundamental questions underlying cellular protein-metabolite interactions in the context of age-related neurodegenerative diseases. My research journey from PhD until my present position has been largely curiosity-driven, and I have strived to seek positions that enable me towards addressing the question – how metabolites influence protein folding and misfolding to sustain fundamental cellular and organismal processes, and how these processes go awry in neurodegenerative diseases?

Employment

• University of California Berkeley Research Scientist
  2022 - Present
• University of California, Berkeley Postdoctoral Research Fellow
  2020 - 2021
• ETH Zurich Visiting Scientist
  2019 - 2019
• Downing College and Centre for Misfolding Diseases, University of Cambridge Independent Research Fellow
  2016 - 2019

Education

• University of Cambridge PhD
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
  ACS Chemical Neuroscience 2023 DOI: 10.1021/acschemneuro.2c00523
  +Save
• Vitamin A and vitamin E metabolites comodulate amyloid-β aggregation
  2021 DOI: 10.1101/2021.10.30.466561
  +Save
• Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  Communications Biology 2021 DOI: 10.1038/s42003-021-02457-8
  +Save
• Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  Communications Biology 2021 DOI: 10.1038/s42003-021-02218-7
  +Save
• Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
  Communications Biology 2021 DOI: 10.1038/s42003-021-01680-7
  +Save
• A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
  Communications Biology 2021 DOI: 10.1038/s42003-020-01490-3
  +Save
• A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins
  ACS Combinatorial Science 2016 DOI: 10.1021/acscombsci.5b00129
  +Save
• An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease
  Science Advances 2016 DOI: 10.1126/sciadv.1501244
  +Save
• Druggability of Intrinsically Disordered Proteins
  Advances in Experimental Medicine and Biology 2015 DOI: 10.1007/978-3-319-20164-1_13
  +Save
• Pathway Analysis of Acinetobacter baylyi: A Combined Bioinformatic and Genomics Approach
  Chemical Biology & Drug Design 2011 DOI: 10.1111/j.1747-0285.2011.01191.x
  +Save